Tandem App
Tandem was a digital health app designed to improve medication adherence. It used a unique "companion" feature that notified a family member via SMS if the user missed a dose. Despite a successful 120-person pilot showing a 2x improvement in adherence, the app failed because the founders mistook "compensated pilot interest" for real-world consumer demand and poor user retention.
The Autopsy
| Section | Details |
|---|---|
| Startup Profile | Founders: Will Sun, Peter Funding: ~$5,000 (Personal savings) |
| Cause of Death | Market Fit: Yes |
| The Critical Mistake | The Pilot Generalizability Error: The founders compensated participants for their initial 6-week pilot. This created an "artificial" environment where users were motivated by money and the "study effect" rather than a genuine desire for the app. Poor Organic Retention: Once the app was free in the wild, retention dropped sharply. Most users didn't last past the first week. High Acquisition Costs: Because the app was free, they had no revenue to offset the high cost of Google/FB ads. They hoped to pivot to enterprise (B2B) sales with insurance companies, but those deals required adoption data they simply didn't have. |
| Key Lessons |
|
Deep Dive
In his interview with Failory, Will Sun discussed the behavioral economics behind their "Companion" feature. The Priceless Notes: During the pilot, one user noted that having their daughter involved was a "bonding experience" rather than nagging. This feedback made the founders "enamored" with the intervention's efficacy. However, they failed to realize that in the real world, the friction of setting up a companion—and the potential social awkwardness of missed alerts—was too high for casual adoption. The Intractable Market: Digital health is notoriously difficult because the "Aha!" moment (not having a heart attack in 10 years) is too far in the future. Without immediate rewards or integration into a doctor's workflow, a medication app is just another "annoying" notification for the user. The Legacy: Tandem is a classic case of "Research-Product Gap." It serves as a reminder that efficacy in a study does not equal interest in a product. Will Sun and his co-founder successfully pivoted their behavioral change expertise into Intent, a weight-loss coaching app that found much stronger consumer demand and paying customers from day one.
Key Lessons
Research-Product Gap: Efficacy in a study does not equal interest in a product.
The "Nagging vs. Nurturing" Balance: The friction of setting up a companion and potential social awkwardness is too high for casual adoption.
The Intractable Market: Digital health is difficult because the "Aha!" moment is too far in the future.